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The interaction of copper ions with peptides was investigated by electrospray mass spectrom-
etry. Two electrospray micro-emitters were compared, the first one with a platinum electrode
using a copper(II) electrolyte solution containing a peptide sample, and the second one with
a sacrificial copper anode in a water/methanol solution containing only a peptide (i.e.,
angiotensin III, bradykinin, or Leu-enkephalin). The former yielded mainly Cu2 complexes
either with histidine residues or with the peptide backbone (Cu complexes can be also formed
due to gas-phase reactions), whereas the latter can generate a mixture of both Cu and Cu2
aqueous complexes that yield different complexation patterns. This study shows that
electrospray emitters with soluble copper anodes enable the study of Cu(I)–peptide
complexes in solution. (J Am Soc Mass Spectrom 2008, 19, 560–568) © 2008 American
Society for Mass Spectrometry
Transition-metal ions and especially copper areessential elements in all living systems [1, 2], butcan also activate pathological disorders [3–6].
Cuprous ions (Cu) are considered soft metal ions
whereas cupric ions (Cu2) are intermediate. In vivo,
the anchor sites for Cu include the thiol moieties of
cysteines and those for Cu2 include the imidazole resi-
dues of histidines [1, 7, 8]. In the gas phase, the binding
sites of Cu2 are quite identical [9] to those observed in
solution whereas arginine becomes the preferred an-
chorage for Cu [10, 11]. Nevertheless, all these inter-
actions are condition-dependent and other groups on a
peptide can also be involved in the coordination of
copper [12, 13]. Metal binding sites can be deduced
by several techniques such as X-ray or nuclear mag-
netic resonance. Of course, mass spectrometry (MS)
has been used for a long time to study inorganic
complexes, especially since the introduction of soft
ionization techniques such as electrospray ionization
(ESI) and matrix-assisted laser desorption/ionization
(MALDI), which are especially adapted to study
bioinorganic complexes [14].
Copper complexes have been studied by different
MS techniques. The traditional method is to mix a
copper salt solution with the sample or by direct
production of cations from metallic copper. For exam-
ple, Cu ions have been generated in the gas phase by
direct ionization of the metal in fast atom bombardment
and in MALDI [15–17]. In aqueous solutions, Cu is
unstable, and specific sample preparations are required
(anaerobic conditions, adequate solvent). When copper
salts are used, Cu ions are produced either by specific
preparation of a copper(I) salt [18, 19] or by gas-phase
reactions using a copper(II) salt. In ESI-MS studies, Cu
ions are produced by reduction of Cu2 during the
ionization process [20–22] even in positive ionization
mode. Lavanant et al. have observed the reduction of
Cu2 complexes by electron capture as well as by
oxidation of the surrounding molecules such as meth-
anol [22]. Gianelli et al. have reported the effect of the
solvent on Cu2 reduction and correlated the produc-
tion of Cu with the ionization energy of alcohols [23].
Cu2 reduction can be favored by increasing the nozzle-
skimmer voltages or the source voltage. Schröder et al.
have also observed this phenomenon by increasing the
cone voltage [24].
An alternative method to produce metal ions is the
direct oxidation of the metallic electrode tip [25–27].
Indeed, in positive ionization mode, the anode used to
provide the spray current is the locus of an oxidation
process that can generate reactive species that can in
turn undergo further reactions, for example for the
on-line tagging of peptides [28–33]. We have demon-
strated that a sacrificial metal electrode coupled to
microchip-ESI-MS can be used for the study of the
metal complexes [34]. Moreover, sacrificial copper elec-
trode leads to the formation either of Cu2 or of Cu
aqueous complexes depending on the ligands present in
solution, as illustrated by using 8-hydroxyquinoline
and bathocuproine [35].
In the present work, we investigate copper–peptide
complexes formed in solution using a copper electrode.
Peptides containing or not containing specific anchor
sites for Cu2 or Cu were sprayed to study the
complexation sites. In addition, the influence of these
cations on peptides fragmentation was studied.
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Experimental
Chemicals
Human angiotensin III (angIII, RVYIHPF, M  931.1
g/mol), angiotensin I/II(1-7) (angI/II, DRVYIHP, M 
899.0 g/mol), (Sar1) angiotensin I/II(1-7) amide (angI/
II-NH2, SarRVYIHP-NH2, M  854.0 g/mol), Leu-
enkephalin (enke, YGGFL, M  555.6 g/mol), were
bought from Bachem (Bubendorf, Switzerland) and
bradykinin (RPPGFSPFR, M  1060.2 g/mol) from
Sigma (St Louis, MO). Cupric chloride dihydrate
(CuCl2 · 2H2O) was from Acros Organics (Geel, Bel-
gium) and methanol from Riedel-de-Haën (Seelze, Ger-
many). Deionized water (18.2 M·cm) was prepared
using a Milli-Q system from Millipore (Bedford, MA).
The peptides were used as received and diluted at a
final concentration of 50 M in 50/50 (vol/vol) MeOH/
H2O. All the solutions were prepared fresh daily.
MS Setup and Microspray Interface
Metal ion on-line complexation was carried out using
a microspray interface described previously [34, 35].
In brief, it consists of a single microchannel (45 m 
120 m  1 cm) polyimide microchip developed by
DiagnoSwiss SA (Monthey, Switzerland) [36, 37]. A
reservoir of polycarbonate (ø  6.5 mm, h  5 mm) was
glued at the inlet of the microchannel. The sample
was loaded (V  100 L) in the reservoir in which a
metallic electrode was immersed. This electrode was
made of platinum wire (blank and copper(II) salt
experiments) or of copper plate (S  30 mm2). Both
electrodes were sanded and rinsed with methanol
before each experiment.
An LCQ DUO ion trap mass spectrometer (Thermo,
San Jose, CA) was used in positive ion mode. The
heated capillary was kept at 200 °C (except for the
experiments with bradykinin). The commercial ESI in-
terface was removed and the microchip was mounted
on a plate fixed on the probe slide adapter of the mass
spectrometer. After the MS power supply onset (U 
3.5 kV) the chip was moved closer to the entrance of the
MS. The current was set between 30 and 80 nA by
adjusting the distance between the microspray outlet
and the entrance of the MS, and monitored by a
nano-ammeter. The ion optics parameters were kept
constant for each peptide studied. The flow rate was
estimated at 300 nL/min according to Morier et al.
[38]. The MS fragments were assigned based on the
calculation of a web-based software, MS-Products
from UCSF (http://prospector.ucsf.edu/prospector/
4.0.8/html/msprod.htm).
Isotopic Distribution Calculation
The isotopes of copper are 63Cu and 65Cu with a natural
abundance of 69.17% and 30.83%, respectively, and a
mass of 62.93 and 64.93 u. Thus, a copper complex
shows a typical isotopic distribution that can be altered
by the different oxidation states of copper. Considering
a mono-charged peptide, 63Cu or 63Cu2 binding
releases one or two protons, respectively, yielding a
theoretical mass difference (with the native peak) of
61.9 or 60.9 Da.
With the aim to distinguish the proportion of the
different oxidation states of copper in the peptide
complexes, theoretical and experimental isotopic distri-
butions were compared. Theoretical isotopes were ob-
tained by the software CS ChemDraw Pro (Cambridge-
Soft Corporation, Cambridge, MA). According to the
isotope of [M  CuI] and [M  CuII  H] or others,
a weighted average of the relative abundance of each
isotope was calculated.
Ii,cal · Ii,CuII 1 · Ii,CuI (1)
where Ii,cal represents the calculated relative abundance of
the isotope i, Ii,Cu(II) the theoretical relative abundance of
the isotope i where only Cu2 is linked, Ii,Cu(I) the theoret-
ical relative abundance of the isotope i where only Cu
is linked, and  is a variable comprised between 0 and
1. The optimum ratio  was obtained with minimizing
the difference (r) between experiments and calculations.
r
i1
n
Ii,cal Ii,exp2 (2)
where Ii,exp stands for the relative abundance obtained
by mass spectrometry. Thus,  gives the ratio Cu2/
Cu coordinated to a peptide. The experimental error
on the relative abundance of isotopes induced by the
data processing is lower than 2%. This error was
calculated for ions of known isotopic composition, such
as [M  H] for angiotensin III. -Values were aver-
aged on several experiments for the same experimental
conditions and the standard deviations were precised
on the given values.
Results and Discussion
Copper–Angiotensin III Complexes
Copper(II) and copper(I) ions that can be produced in
solution by a sacrificial copper electrode present a good
affinity for histidine and arginine, respectively. There-
fore, a histidine- and arginine-containing peptide,
namely angiotensin III (RVYIHPF), has been chosen to
study the relative complexation properties of the two
oxidation states. Experiments were first carried out
classically with a Pt electrode for reference (data not
shown). The mono and doubly charged peptides were
observed at m/z  931.5 Th and at m/z  466.3 Th,
respectively, and no fragment ions could be detected.
When the copper electrode is used described above,
copper ions are electrogenerated by anodic dissolution
of the electrode and Cun–angIII complexes are formed
as clearly shown in Figure 1a where two copper com-
plexes can be observed. The mono-copper complex
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(copper:peptide, 1:1) at m/z  992.2 Th, previously
reported [34, 39], appeared straightaway whilst the
bimetallic complex (2:1) at m/z  1053.2 Th appeared
after few minutes of electrolysis. Focusing on the isoto-
pic distribution of the mono-copper complex, four
peaks can mainly be observed where the relative abun-
dances show in fact an overlap of two oxidation states.
To determine the ratio between Cu2 and Cu, the
theoretical isotopic distribution has been calculated (see
Table 1). In comparison with the experiment, these data
clearly show that the mono-copper complexes are con-
stituted by 76% 3% of Cu2 under these experimental
conditions. This can be due either to the binding of
copper ions on different sites, (RVYIH(Cu2)PF or
R(Cu)VYIHPF), or to a mixed population of Cu2/
Cu on a given site, (e.g., RVYIH(Cu2/)PF), induced
by an in situ reduction of Cu2–histidine complexes in
the gas phase [20, 22–24, 35]. As the copper electrode is
able to produce either Cu2 or Cu aqueous ions,
Cu2–histidine and/or Cu–arginine complexes can in
Figure 1. Mass spectra of angiotensin III (RVYIHPF, 50 M) in 50/50 (vol/vol) MeOH/H2O
obtained with (a) a Cu electrode, t  59 min, (same pattern was observed after 25 min) and (b) a Pt
electrode in presence of CuCl2 at 400 M; (filled triangle) an-ions bound to Cu
; (asterisk) x6 bound
to Cu. Cu2 ions generated from either copper electrode or copper(II) salt induce the fragmentation
of angiotensin III. Cu electrode clearly gives the access to Cu complexes.
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principle be concomitantly formed. The peak pattern
observed for the bimetallic complex at m/z  1053.2 Th
also shows the presence of both Cu2 and Cu species
(data not shown).
In contrast, the experiments performed with a plati-
num electrode (with the same MS parameters) in the
presence of CuCl2 added to the peptide solution re-
vealed only a mono-copper complex at m/z  992.3 Th
(Figure 1b) with a lower conversion rate. Moreover, the
copper(II) salt concentration required (400 M) had to
be in excess compared with that of the peptide (50 M)
to achieve an equivalent result to that obtained with the
copper electrode (5 M Cu2 electrogenerated in 30 min
according to the Faraday’s law). These results suggest a
difference of reactivity between copper ions added as a
salt or electrogenerated. In the first case, the counter-
ions, namely chloride, can lead to the formation of differ-
ent chloride complexes, thereby decreasing the free ion
concentration whereas the electrogenerated copper ions
can only be complexed by water or methanol. Then, these
cations are more reactive towards angiotensin III, yielding
a higher conversion rate. In addition, reactions at the
surface of the electrode could also contribute to this
phenomenon.
Copper–Angiotensin III Complexes Fragmentation
The binding of copper ions to angIII was found to
induce its fragmentation (Figure 1). The degradation
induced by electrogenerated copper ions presents all the
a-type fragments linked to one copper ion (Figure 1a,
Scheme 1a). All these fragments contain an arginine resi-
due, which is able to coordinate Cu. In comparison,
CuCl2 also induced a fragmentation, but only histidine-
containing fragments complexed with Cu are observed
(Figure 1b, Scheme 1b). The fragments an,n  5 are not
complexed and no copper ions were found anchored to
arginine. These Cu–histidine-containing fragments must
result from Cu2 ions initially bound to histidine but
reduced in the gas phase during the fragmentation. The
fragmentation patterns (not induced by MS/MS experi-
ments) show that the mono-copper complex discussed
above is a mixture of two complexes, one with Cu2
bound to histidine and one with Cu bound to arginine.
When Cu2 binds to the histidine of angIII, the
C-terminus is involved in the formation of a tetra-
coordinated complex including the oxygen of the car-
boxylate [7]. Figure 1a shows, for the native peak
tagged, a loss of 43.9 Da corresponding to the loss of the
carboxylate group of the C-terminus in which the
oxidation state of Cu2 is maintained, as observed by
several studies [39, 40]. Indeed, focusing on the isotopic
distributions of the mono-copper complex peaks and of
the decarboxylated one, the calculations gave 76% 3%
(see Table 1) and 96%  3% (data not shown) of Cu2,
respectively. This suggests that the loss of CO2 is
induced by the presence of Cu2 and not its reduction.
However, the other fragments are complexed with Cu
(the isotopic distribution of the an-ions bound to copper
shows 100% of Cu). These complexed an-ions can be
explained as follows. After the loss of CO2, an electron-
transfer reducing Cu2 to Cu oxidizes the peptide and
the observed complexes are coordinated with Cu.
When the fragmentation reaches the histidine, copper
unbinds from the peptide and stays on the departing
histidine (experiments performed with angiotensin II
(DRVYIHPF) showed a (a6y3) fragment linked to Cu
,
i.e., the immonium ion of histidine, corroborating this
particular loss with Cu ions). In addition, the frag-
ments an,n  5 (Figure 1a) are bound to Cu
. Therefore,
it seems that the complexed ions a5 and a6 come from a
monometallic complex and that the an,n  5 fragments
come from a bimetallic peptide after release of a Cu-
Table 1. Relative abundance of the isotopes of Cun–angiotensin
III complexes
m/z/Th
I/%
Cun–angIII
experimental
Cu2–angIII
theoreticala
Cu–angIII
theoreticala
Cun–angIII
calculatedb
992.2 100  0 100 0 100  4
993.2 89  5 55 100 87  4
994.3 76  6 61 55 78  4
995.3 45  3 28 61 47  4
996.2 20  3 7 28 16  4
997.2 7  1 1 8 4  4
aObtained from the software CS ChemDraw Pro.
bCalculated according to eq 1 with   0.76  0.03.
Scheme 1. Fragmentation of angiotensin III induced by copper ions. Experiments ran with (a) a Cu
electrode and (b) a Pt electrode in presence of CuCl2.
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histidine complex (Scheme 1a). This fragmentation is
also coherent with the experiment run with the platinum
electrode in presence of CuCl2, where the histidine-free
fragments are not linked to copper (Figure 1b, Scheme
1b). In these peaks, only the histidine-containing frag-
ments are complexed (with Cu) and all the fragments
are present. All these experiments suggest that the
initiation of the fragmentation is induced by Cu2.
To understand the influence of the C-terminus car-
boxylate on the fragmentation process, angiotensin
I/II(1-7) and (Sar1)angiotensin I/II(1-7) amide were
sprayed with a copper electrode (Figure 2). A quick
view of these spectra clearly exhibits the difference. The
first peptide, DRVYIHP, enables the binding of two
Cu2 ions by the presence of two anchor sites, i.e.,
aspartic acid and histidine (Figure 2a). Consequently,
these sites undergo the formation of a bimetallic com-
plex at m/z  1021.1 Th (the monometallic complex
being at m/z  960.2 Th). As with angIII, the decarbox-
ylation occurs and then Cu2 can oxidize the peptide.
All [an,n 	 5 Cu
IH] fragments and immonium ions
of arginine bound to copper ([(a2y6)  Cu
I  H]) are
Figure 2. Mass spectra of (a) angiotensin I/II (DRVYIHP, 50 M), t 1h23, and (b) (Sar1)angiotensin
I/II amide (SarRVYIHP-NH2, 50 M), t  1h21, in 50/50 (vol/vol) MeOH/H2O performed with a Cu
electrode; (asterisk) doubly charged species. The amidation of the C-terminus stops the fragmentation
induced by copper ions.
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also observed. In contrast, the peptide with the modi-
fied C-terminus (SarRVYIHP-NH2) does not show a
clear fragmentation (Figure 2b). There is only one
adduct of Cu2 at m/z  915.3 Th, which loses 43.9 Da
corresponding to the loss of the fragment a1, the immo-
nium moiety from N-methylglycine (Sar group).
These mass spectra confirm the influence of the
C-terminus on the fragmentation pathway. The replace-
ment of aspartic acid by N-methylglycine prevents the
addition of a copper ion at the N-terminus but does not
change the binding to the arginine. When the carboxy-
late group is unmodified, the histidine-containing frag-
ment [a6  Cu
I  H] is intense and many others
fragments, including [(a2y6)  Cu
I  H] correspond-
ing to a copper ion linked to arginine, are observed.
These results are consistent with the interpretation
made for angiotensin III. When the amidated peptide is
studied, only a mono-copper complex and a fragment
[a2  Cu
I  H] are present. No histidine-containing
fragments are observed. Copper ions bind to arginine
when the carboxylate group is not free and probably
with the participation of nitrogen from the amide
bound. This adduct being a Cu2 complex, a binding
between the guanidine and the imidazole residues is
not excluded. The loss of 43.9 Da corresponds to
the fragment a1 and the peak at m/z  871.4 Th is [x6 
CuI  H]. The amidation of the C-terminus stops the
fragmentation due to the formation of a Cu2–histidine
complex, as reported by Hu and Loo [39].
Copper–Bradykinin Complexes
Histidine-free peptides were then used to test the
production of Cu–peptide complexes from a sacrificial
copper electrode. Bradykinin (RPPGFSPFR) contains
two arginines able to bind theoretically two Cu ions.
Again, this peptide was sprayed with a copper elec-
trode and with a platinum electrode in presence of
CuCl2. The most intense peak was the mono charged
peptide at m/z  1060.6 Th. With both methods, the
addition of one Cu ion was observed at m/z  1122.4
Th even if the proportion of Cu was less important
when using a copper(II) salt (roughly 65% versus 90%
of Cu with the copper electrode). According to the
peptide structure, the formation of Cu complexes
should be enhanced and the spray condition could
facilitate the Cu2 reduction in the gas phase. The
comparison between the use of a copper electrode and
a copper(II) salt was not straightforward. Decreasing
the heated capillary temperature has been found in this
case to enhance the formation of doubly charged pep-
tides and also the formation of Cu2 complexes, prob-
ably helped by a lower desolvation rate. Thus, the
temperature of the heated capillary was fixed at 100 °C
instead of 200 °C. The relative abundance of the doubly
charged bradykinin (m/z  530.9 Th) and that of mono
charged at m/z  1060.6 Th were 100% and 20%,
respectively. First, bradykinin was sprayed with a cop-
per electrode and the oxidation produced mainly a
doubly charged Cu–bradykinin complex at m/z 
561.7 Th. However, after 15 min the proportion changed
and a Cu2 complex was observed to reach 
60% and
80% of Cu2 after 30 and 60 min of electrospray,
respectively. According to the soft ionization, the mass
spectrum of bradykinin obtained with a platinum elec-
trode in presence of CuCl2 shows the formation of a
Cu2–bradykinin complex at m/z  561.1 Th. Indeed,
under these conditions, this copper adduct was only
formed by Cu2. Bradykinin has two anchor sites for
Cu, via arginine [10, 11], but also can complex Cu2
via the amide group of the peptide backbone or differ-
ent part of the amino acids side chain [12, 13].
Copper–bradykinin complexes did not fragment like
the copper-angiotensin III complexes. Collision-induced
dissociation (CID) was thus required. Table 2 summa-
rizes the fragment ions coming from tandem mass
spectrometry (at 33% of collision energy) of [M 
CuII]2 and [M  H  CuI]2. The CID spectrum
patterns and several peaks are different. For the Cu2
complexes, the most intense peaks are the immonium
ions of arginine bound to Cu (either from the N-
terminus or the C-terminus after a CO2 loss) and several
fragments bound to Cu2. The presence of Cu2 in-
duces the loss of CO2 (44 Da), of formaldehyde coming
from the serine side chain (CH2O, 30 Da) [41, 42], of
water and the loss of a part of guanidine moiety from
arginine (HNCNH, 42 Da) [41, 43]. Several a- and
b-ions (a8, a6, a5, b4) are linked to Cu
 (including the
immonium ion of arginine), suggesting the N-terminus
arginine is the anchor site after Cu2 reduction. Intense
x- and y-ions (x8, x7, y7) are mainly linked to Cu
2. In
addition, internal fragments corresponding to PPGF
and FSP or SPF are also complexed with Cu2. As a
result, copper(II) seems fixed in the middle of the
structure and copper(I), probably coming from Cu2
reduction, is coordinated to one of the arginine. As for
the CID spectrum of [M  H  CuI]2, the fragments
are coordinated with Cu. The loss of the serine side
chain, water, and part of the guanidine represents the
most abundant species and the decarboxylation is not
observed (phenomenon also observed with angIII
where CO2 loss was related to Cu
2). Several a- and
b-ions support the formation of Cu complexes at the
N-terminus and the immonium ion of arginine (less
abundant compared with the fragmentation of [M 
CuII]2) corroborates the binding between copper(I)
and arginine. Taking into account the absence of CO2
loss and the relative weak abundance of [Im R  CuI]
(27.2%) compared with the fragmentation of the Cu2-
complex (100%), it seems that Cu (produced at the
copper electrode) is linked to the N-terminus arginine;
and that [Im R  CuI] produced from CuCl2 stems
from the C-terminus as well as the N-terminus arginine.
These CID spectrum patterns emphasize the difference
in Cu2 and Cu binding site on bradykinin. In the
absence of histidine, the oxidation of the copper elec-
trode produced copper(I) ions able to bind at the
arginine. On the other hand, copper(II) ions coming
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from the salt are fixed in the middle of the structure but
are also able to produce Cu-arginine complexes after
reduction of Cu2-bradykinin complexes during CID
experiment. These fragments suggest a rearrangement
in the copper coordination after the reduction of Cu2.
Copper–Enkephalin Complexes
Leu-enkephalin (YGGFL) was finally used as a histidine
and arginine free sequence (Table 3). In the absence of
coordination sites, the metallic ions will anchor to the
amide groups of the peptide backbone via nitrogen [12].
The mass spectra obtained with a Pt electrode show the
presence of the mono charged peptides at m/z  556.2
Th, the fragments b2, b3, a4, and b4, and also the
formation of noncovalent dimers [44, 45] and trimers at
m/z  1111.2 Th and 1665.9 Th. The use of a copper
electrode instead of a platinum wire produced two
copper adducts at m/z  618.1 Th and m/z  679.9 Th.
The 1:1 complex was formed after a few seconds,
whereas the 2:1 complex appeared after a few minutes.
The mono-copper complex corresponds to a mixture
of [M  CuI] (m/z  618.1 Th) and [M  CuII  H]
(m/z  617.1 Th) in equivalent quantity according to the
isotopic distribution. The dimer is mainly complexed
with one Cu2 (m/z  1172.1 Th) and two Cu ions
(m/z  1235.1 Th). As observed above, the copper ions
induce some fragmentations. The losses of CO2 and
then the radical propyl and the tyrosine side chain
were observed at m/z  573.1 Th, m/z  530.1 Th and
m/z  510.0 Th, respectively. These two last frag-
ments are formed of Cu and come from the reduc-
tion of Cu2, as explained by Tabet and coworkers
[40, 46]. Indeed, the fragmentation of [M  CuI]
cannot give these fragments. Finally, MS/MS exper-
iments (data not shown) performed on the peaks
m/z  618.1 Th and m/z  530.0 Th confirmed the
binding site of Cu in the middle of the sequence, i.e.,
on Gly. Obviously, the coordination is achieved by
the peptidic bond.
When a copper(II) salt is used a platinum electrode,
the results are almost identical and the difference stems
mainly from the ratio between copper ions and Leu-
enkephalin. The first adduct (m/z  616.9 Th) is mainly
formed by Cu2 (roughly 80%) and the bimetallic
complex is [M  2CuI  H] at m/z  680.0 Th. As for
the fragments, the same pattern as before has been
observed. However, few differences in the ratio must be
pointed out. The isotopic distribution around m/z 
510.0 Th ([M  CuI  H  ·C7H7O]
) revealed the
presence of a Cu2 complex at m/z  511.0 Th ([M 
CuII  H  C7H6O]
, not observed with the copper
electrode). This fragment corresponds to the loss of
105.9 Da. As described by Bossée et al. [47], this
molecule is obtained by the loss of the tyrosine moiety
without Cu2 reduction. Finally, the binding site of
Cu2 remains the same as before (according to CID
experiments) even if the fragmentation of [a4  Cu
I 
H] shows a copper adduct on YG structure. Further-
more, MS/MS experiments carried out on the bimetallic
complex at m/z  680.0 Th highlighted the binding of
two Cu ions on the GF part of Leu-enkephalin.
The experiment performed with the sacrificial cop-
per electrode produced more Cu ions than the one
carried out with a copper(II) salt. Approximately 40% of
Cu were produced by the anodic dissolution of the
copper electrode. The fragments (those induced by the
metastable ions formed by addition of copper ions, see
difference in Table 3) are most abundant when using
CuCl2. These fragments mainly stem from the reduction
of Cu2 complexes in Cu and are explainable by the
higher presence of mono-copper(II) complex. Indeed, the
fragments [M  CuI  H  CO2  ·C3H7]
 and
[M  CuI  H  ·C7H7O]
 can only come from Cu2
reduction. These experiments are equivalent although the
copper electrode produces more Cu ions. Moreover, the
Table 3. Peaks observed when spraying Leu-enkephalin (50 M) with different electrodes or in presence of CuCl2 (50 M)
m/z/Th
I/%
Pt electrode Cu electrodea Pt electrode, CuCl2
[M  2CuI  H] 680 — 8 11
[M  CuI]b 618 — 49 62
[M  CuII  H]b 617 — 39 100
[M  K] 594 42 99 11
[M  Na] 578 78 100 30
[M  CuII  H  CO2]
 573 — 25 62
[M  H] 556 100 52 90
[M  CuI  H  CO2  ·C3H7]
 530 — 24 54
[M  CuI  H  ·C7H7O]
 510 — 9 14
[a4  Cu
I  H] 459 — 11 26
b4 425 7 6 10
a4 397 6 6 12
b3 278 4 — 14
b2 221 2 2 6
aObtained after 30 min of experiment.
bI is influenced by the isotopic distributions (see text for details).
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Cu and Cu2 anchor sites are the same in this sequence
in absence of particular copper binding sites.
Conclusions
As reported previously for small molecules, sacrificial
copper electrode leads to the formation of either cop-
per(I) or copper(II) aqueous complexes depending on
the ligands present in solution. The present work high-
lights the behavior of a soluble copper anode during the
analysis of cysteine-free peptides in positive ionization
mode. Indeed, copper cations can oxidize the thiol
moiety of cysteine to form disulfide bridges. Further
experiments will be performed in such direction and
with more complex samples.
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